001367 海森药业
2025/122024/122023/122022/122021/12

盈利能力分析
净资产收益率 ROE (%)9.5769.45112.18225.91529.362
总资产报酬率 ROA (%)8.7218.67110.98020.63222.356
投入资产回报率 ROIC (%)9.3999.27711.79923.44826.210

边际利润分析
销售毛利率 (%)45.60041.47241.07937.36139.976
营业利润率 (%)29.46830.12630.68928.77227.990
息税前利润/营业总收入 (%)28.50826.22526.35126.53928.151
净利润/营业总收入 (%)25.52925.99326.33525.44824.165

收益指标分析
经营活动净收益/利润总额(%)96.36497.67199.20496.03197.329
价值变动净收益/利润总额(%)4.2822.1160.265-3.1071.337
营业外收支净额/利润总额(%)-0.056-0.184-1.0771.728-0.324

偿债能力分析
流动比率 (X)11.01410.30514.9545.3503.507
速动比率 (X)10.0819.35912.9323.6392.487
资产负债率 (%)8.3729.5456.83217.07424.337
带息债务/全部投入资本 (%)0.6480.2680.9653.51010.403
股东权益/带息债务 (%)15,138.75736,650.92210,154.5582,673.594830.572
股东权益/负债合计 (%)1,094.497947.6751,363.662485.695310.893
利息保障倍数 (X)-30.224-6.819-6.569-9.690111.898

营运能力分析
应收账款周转天数 (天)47.27840.17443.15228.24523.468
存货周转天数 (天)139.218179.232232.089168.285147.337